Augmented Berlin-Frankfurt-Munster (BFM) Therapy for Adolescent/Young Adults With Acute Lymphoblastic Leukemia or Acute Lymphoblastic Lymphoma

NCT00866749 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Lymphoblastic Leukemia
Lymphoblastic Lymphoma

Interventions

DRUG: Daunorubicin
DRUG: Vincristine
DRUG: PEG-asparaginase
DRUG: Intrathecal Methotrexate
DRUG: Cyclophosphamide
DRUG: Cytarabine
DRUG: Mercaptopurine
DRUG: Methotrexate
DRUG: Doxorubicin
DRUG: Thioguanine

Sponsor

M.D. Anderson Cancer Center